NEK7 mediates ESRD-associated endothelial injury by activating the NLRP3 inflammasome
- 21 July 2025
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 163, 115236
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81700651)
- Graduate Research and Innovation Projects of Jiangsu Province (KYCX25_2154, JX12214136)
This publication has 64 references indexed in Scilit:
- Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapiesBiochemical Pharmacology, 2022
- NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseasesInflammopharmacology, 2022
- Chronic kidney disease measures for cardiovascular risk predictionAtherosclerosis, 2021
- Cardiovascular disease in patients with chronic kidney diseaseHerz, 2021
- Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stressBiochemical and Biophysical Research Communications, 2020
- MicroRNA-214 targets COX-2 to antagonize indoxyl sulfate (IS)-induced endothelial cell apoptosisApoptosis, 2019
- Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injuryActa Pharmaceutica Sinica B, 2019
- Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasomeBiochemical and Biophysical Research Communications, 2016
- Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathwayArchives of Toxicology, 2015
- In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statinAngiogenesis, 2013